A Placebo-Controlled Trial of Atomoxetine in Marijuana-Dependent Individuals with Attention Deficit Hyperactivity Disorder

被引：59
|
作者：
McRae-Clark, Aimee L. [1 ]
Carter, Rickey E. [2 ]
Killeen, Therese K. [1 ]
Carpenter, Matthew J. [1 ]
White, Kathleen G. [1 ]
Brady, Kathleen T. [1 ]
机构：
[1] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
来源：
AMERICAN JOURNAL ON ADDICTIONS | 2010年 / 19卷 / 06期
关键词：
DEFICIT/HYPERACTIVITY DISORDER; SUBSTANCE-ABUSE; ADULT ADHD; SUBTHRESHOLD DIAGNOSES; LATE-ONSET; FOLLOW-UP; ALCOHOL; METHYLPHENIDATE; COMORBIDITY; COGNITION;
D O I：
10.1111/j.1521-0391.2010.00076.x
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
This study evaluated the effects of atomoxetine on the symptoms of attention deficit hyperactivity disorder (ADHD) and marijuana use in marijuana-dependent adults. In conjunction with motivational interviewing, participants received either atomoxetine (n = 19) or matching placebo (n = 19) for 12 weeks. Participants randomized to atomoxetine had greater improvement in ADHD on the Clinical Global Impression-Improvement scale than participants treated with placebo. No treatment group differences in self-rated ADHD symptoms, overall Wender-Reimherr Adult Attention Deficit Disorder Scale scores, or marijuana use outcomes were noted. These results suggest that atomoxetine may improve some ADHD symptoms but does not reduce marijuana use in this population. (Am J Addict 2010;00:1-9).
引用
收藏
页码：481 / 489
页数：9
相关论文
共 50 条
  • [41] A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder
    Scahill, L
    Chappell, PB
    Kim, YS
    Schultz, RT
    Katsovich, L
    Shepherd, E
    Arnsten, AFT
    Cohen, DJ
    Leckman, JF
    AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (07): : 1067 - 1074
  • [42] Placebo-controlled study examining effects of selegiline in children with attention-deficit/hyperactivity disorder
    Rubinstein, Suzanne
    Malone, Molly A.
    Roberts, Wendy
    Logan, William J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (04) : 404 - 415
  • [43] Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial
    Kelsey, DK
    Sumner, CR
    Casat, CD
    Coury, DL
    Quintana, H
    Saylor, KE
    Sutton, VK
    Gonzales, J
    Malcolm, SK
    Schuh, KJ
    Allen, AJ
    PEDIATRICS, 2004, 114 (01) : E1 - E8
  • [44] Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine
    Upadhyaya, Himanshu
    Adler, Lenard A.
    Casas, Miguel
    Kutzelnigg, Alexandra
    Williams, David
    Tanaka, Yoko
    Arsenault, Jody
    Escobar, Rodrigo
    Allen, Albert J.
    CHILD AND ADOLESCENT PSYCHIATRY AND MENTAL HEALTH, 2013, 7
  • [45] Atomoxetine for hyperactivity in autism spectrum disorders: Placebo-controlled crossover pilot trial
    Arnold, L. Eugene
    Aman, Michael G.
    Cook, Amelia M.
    Witwer, Andrea N.
    Hall, Kristy L.
    Thompson, Susan
    Ramadan, Yaser
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (10): : 1196 - 1205
  • [46] Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine
    Himanshu Upadhyaya
    Lenard A Adler
    Miguel Casas
    Alexandra Kutzelnigg
    David Williams
    Yoko Tanaka
    Jody Arsenault
    Rodrigo Escobar
    Albert J Allen
    Child and Adolescent Psychiatry and Mental Health, 7
  • [47] Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents
    Svanborg, Par
    Thernlund, Gunilla
    Gustafsson, Per A.
    Hagglof, Bruno
    Schacht, Alexander
    Kadesjo, Bjorn
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2009, 18 (12) : 725 - 735
  • [48] Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents
    Pär Svanborg
    Gunilla Thernlund
    Per A. Gustafsson
    Bruno Hägglöf
    Alexander Schacht
    Björn Kadesjö
    European Child & Adolescent Psychiatry, 2009, 18
  • [49] Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder
    Simpson, D
    Plosker, GL
    CNS DRUGS, 2004, 18 (06) : 397 - 401
  • [50] Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder
    Witcher, JW
    Long, A
    Smith, B
    Sauer, JM
    Heilgenstein, J
    Wilens, T
    Spencer, T
    Biederman, J
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) : 53 - 63
12345